A retinal imaging platform that uses artificial intelligence to evaluate eye scans for biomarkers of Alzheimer’s disease and other neurological disorders has received the FDA’s “Breakthrough Device” ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted breakthrough device designation to a retinal imaging platform that evaluates patients for ...

Alzheimer's disease is the leading cause of dementia in the U.S., with approximately 5.4 million currently affected and an estimated 16 million by 2050. Damage to the brain from Alzheimer's disease ...

Alzheimer's disease is the leading cause of dementia in the U.S., with approximately 5.4 million currently affected and an estimated 16 million by 2050. Damage to the brain from Alzheimer's disease ...

Diagnosis of Alzheimer's disease (AD) as early as possible in the progress of the condition continues to present a major global health challenge. One potential bioimaging approach has been to look at ...

MONTREAL, May 13, 2020 /CNW Telbec/ - Optina Diagnostics announces today that it received 510(k) clearance for its ophthalmic camera, the Mydriatic Hyperspectral Retinal Camera (MHRC-C1), by the U.S.

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...